Should aciclovir be given to all patients presenting with acute liver failure of unknown etiology?: Commentary

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 6, 2008, Pages 298-299

  Fontana, Robert J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CORTICOSTEROID DERIVATIVE; PROSTAGLANDIN; VIRUS DNA;

DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; LIVER FAILURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SHORT SURVEY; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 44949114264     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1128     Document Type: Short Survey

References (5)

1. Ostapowicz G et al. (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947-954
2. Stravitz RT et al. (2007) Intensive care of patients with acute liver failure: Recommendations of the US Acute Liver Failure Study Group. Crit Care Med 35: 2498-2508
3. Peters DJ et al. (2000) Herpes simplex-induced fulminant hepatitis in adults: A call for empiric therapy. Dig Dis Sci 45 2399-2404
4. Mason A et al. (1996) Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure. Hepatology 24:1361-1365
5. Levitsky J et al. (2007) Herpes simplex virus in acute liver failure [abstract]. Gastroenterol 132 (Suppl 2): A1717